- Home
- ZNTL vs PGAC Comparison
ZNTL vs PGAC Comparison
Compare ZNTL & PGAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- PGAC
- Stock Information
- Founded
- ZNTL 2014
- PGAC 2024
- Country
- ZNTL United States
- PGAC United States
- Employees
- ZNTL N/A
- PGAC N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- PGAC
- Sector
- ZNTL Health Care
- PGAC
- Exchange
- ZNTL Nasdaq
- PGAC Nasdaq
- Market Cap
- ZNTL 105.8M
- PGAC 112.8M
- IPO Year
- ZNTL 2020
- PGAC N/A
- Fundamental
- Price
- ZNTL $1.42
- PGAC $10.24
- Analyst Decision
- ZNTL Buy
- PGAC
- Analyst Count
- ZNTL 6
- PGAC 0
- Target Price
- ZNTL $6.53
- PGAC N/A
- AVG Volume (30 Days)
- ZNTL 729.8K
- PGAC 20.5K
- Earning Date
- ZNTL 11-11-2025
- PGAC 08-14-2025
- Dividend Yield
- ZNTL N/A
- PGAC N/A
- EPS Growth
- ZNTL N/A
- PGAC N/A
- EPS
- ZNTL N/A
- PGAC N/A
- Revenue
- ZNTL $26,865,000.00
- PGAC N/A
- Revenue This Year
- ZNTL N/A
- PGAC N/A
- Revenue Next Year
- ZNTL N/A
- PGAC N/A
- P/E Ratio
- ZNTL N/A
- PGAC N/A
- Revenue Growth
- ZNTL N/A
- PGAC N/A
- 52 Week Low
- ZNTL $1.01
- PGAC $10.20
- 52 Week High
- ZNTL $4.46
- PGAC $10.29
- Technical
- Relative Strength Index (RSI)
- ZNTL 39.87
- PGAC N/A
- Support Level
- ZNTL $1.40
- PGAC N/A
- Resistance Level
- ZNTL $2.02
- PGAC N/A
- Average True Range (ATR)
- ZNTL 0.11
- PGAC 0.00
- MACD
- ZNTL -0.05
- PGAC 0.00
- Stochastic Oscillator
- ZNTL 4.76
- PGAC 0.00
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About PGAC Pantages Capital Acquisition Corporation Class A Ordinary Shares
Pantages Capital Acquisition Corp is a blank check company.